The chips are benefited from three core technologies of HICOMP: advanced microfluidics design, Micro-injection molding,
Surface modification and protein immobilization.
The sample is automatically drived without any external power, which is especially suitable to the detection of antigen-antibody reaction.
Small volume of whole blood/plasma samples
Real-time, convenient, POCT;
Separation of injection, reaction and detection;
Self-driven, free of external drive;
Immunofluorescence quantitative detection with high precision;
troponin (CTNI), myoglobin (MYO), creatine kinase-MB (CK-MB), brain natriuretic peptide (BNP), D-Dimer, immunoglobulin (IgG/ IgM/ IgE), C-reactive protein (CRP) etc.
Microfluidics is a next-generation diagnostics technology that allows us to automatically complete analyses by integrating basic actions on tiny chips measuring just a few square centimeters such as pre-treatment, reaction, separation, and detection in dealing with chemical samples, and cell culture growing, sorting, and lysis in life science.
4.Low reagent consumption
5.Low sample consumption
6.No cross contamination
HICOMP masters cutting-edge mold technologies including core process and strategies for microinjection molding. HICOMP provides trans-dimension microinjection molding products with micro channel,
reservoir and other complicated
HICOMP provides chip surface quick modification including long-life-time hydrophobic/hydrophilic
surfaces, and sample embedding with chip sealing